How we make implants disappear after operations Andreas Karau June 21, 2016, Essen, Germany.

Slides:



Advertisements
Similar presentations
Medical Biotechnology Regenerative Medicine
Advertisements

Non-ablative Skin Rejuvenation Connor Walsh. The Problem Currently, millions of Americans are aggravated by some type of skin defect such as a scar, a.
Advanced Treatment Options for Knee Arthritis Surgeon Name Clinic Name Clinic Address Phone Number Web Address.
REGENERATIVE MEDICINE
2010 Southeast Region Technology Transfer Director’s Meeting Scott Sewell Vice President Technology Acquisition & Development.
Artificial Heart Valves By: Brian Volpe. What is it? An artificial heart valve is a mechanism that mimics the function of a human heart valve It’s used.
1 POLYMERIC BIOMATERIALS VASCULAR GRAFTS. 2 Biomaterials The normal description of a biomaterial is “any substance (other than a drug) or combination.
REGENERATION OF BONE TISSUE THROUGH STEM CELLS FOR THE TREATMENT OF OSTEOARTHRITIS Allen Wang and Sravan Rajathilak Arthritis Arthritis is a degenerative.
Francine Goulet, Ph.D., pht Nanomedical Biological Device in Development for Torn ACL Replacement.
Tissue Engineering: a new healthcare technology. Biomaterials Biomaterials science may be the most multidisciplinary of all the sciences which encompasses.
Bone Fracture. Recall: Three types of Stress: Three types of Stress: Tension Tension Compression Compression Shear Shear.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Tissue Engineering By: Cassie Kuchta & Tim Rohman.
Therapeutic Peptides for Cardiovascular Disease and Cancer Cam Patterson, MD, MBA, FACC, FAHA Ernest and Hazel Craige Distinguished Professor of Cardiovascular.
Stem Cells and Regenerative Medicine. “Glow-in-the-dark” dogs!
Use of Dendrimers as a Biological Sensing of Mechanical Heart Valve Thrombosis.
Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.
CRICOS: 00116K Biomedical Engineer: Design products and procedures that solve medical problems. These include artificial organs, prostheses, instrumentation,
Rotary Minute & Facebook Campaign – Easy Facts Did you know? 1 in 3 people will need a blood transfusion during their lifetime! 1 in 7 patients who enter.
BURN TREATMENT AND TISSUE ENGINEERING OF THE SKIN Presentation By: Cara Nunez.
Vitrasert Ganciclovir Intraocular Implant This is a reservoir style implant used for the delivery of the anti-viral drug ganciclovir to treat AIDs-related.
Biomedical Engineering Overview
THERAPEUTIC EXERCISES Dr. Michael Banoub Sorour
1 Autologous Liver Cell Transplantation A new approach to liver disease therapy Presentation at ESAO Conference, September 6 th 2007, Krems Prof. Toni.
Defining the right clinical problems for nanotechnology Table 2 John S. Oghalai, MD.
BIOENGINEERING BODY PARTS AND ORGANS FOR TRANSPLANT
With sufficient amounts of calcium in the body nerve responses are much better. As calcium decrease nerve function can be altered. If the body does not.
Bone Fractures.
Bone Repair and Biomedical Engineering. Repairing Bones: Overview Some serious breaks need the aid of engineers because: – Need to restore function and.
The Bio-Artificial Liver
Tissue Engineering Reagan Coats. Organ Transplantation In the United States, the number of patients on the waiting list rose to over 95,000 in the year.
The application can be categorized into followings: Hard Tissue Applications Soft Tissue Applications Most of living tissues i.e. bone, collagen, cartilage.
Material engineering VS. Bioengineering In the beginning, material application was a problem of material choice. These days, scientists can device their.
Biological Properties ISSUES TO ADDRESS... Biomaterials definition Different types of interaction between body and foreign material What are main characteristics.
Categories of Biomaterials
Diabetes  23.6 million people have diabetes  7.8% of population  1.6 million people ages 20 or older were diagnosed with diabetes in  All of.
Tissue engineering uses an artificially stimulated cell proliferation by using suitable supports made of nanomaterials, and growth factors. As an example,
Gene Therapy. What is Gene Therapy? Gene Therapy is the insertion of genes into an individual’s cells and tissues to treat a disease. Gene Therapy is.
Scaffold Degradation Part II Effect of Ionic Strength on Scaffold Biodegradability Jay Sehgal North Allegheny Intermediate High School.
School of Mechanical, Materials and Manufacturing Engineering About this course Biomedical industries provide a rich diversity.
Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.
Targeted Drug Therapeutics An overview of our technologies and their potential 505(b)(2) applications Sino-American Regulatory Consulting Alliance Yongtian.
CONCLUSION It’s clear that shoulder prosthesis is efficient in comfort and function restoration, and its main visible benefits are pain relief and the.
Lordosis (Depuy Bengal® Stackable Cage System)
IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.
OUTCOME OF SPINE SURGERY IN ELDORET
Bone Marrow Transplant
BIOMEDICAL ENGINEERING
Cardiovascular Disease
Medical Device Issues Prof. David Woolfson.
Senior Science Bionics
Bioabsorbable DES and Biodegradable Polymers – FDA View
The REVA Tyrosine Polycarbonate Bioresorbable Stent: Lessons Learned and Future Directions Robert K. Schultz, PhD.
CRT 2010 Washington DC, January 21, 2010
what is carotid angioplasty?
Prosthetics.
© 2017 Global Market Insights, Inc. USA. All Rights Reserved Biodegradable Bone Graft Polymers Market outlook, regional growth & industry share by 2024:
Regenerative Medicine
Tissue Engineering.
Growing Blood Vessels John Rawls.
Trinity College Dublin 12 April 2018 Hugh McMahon
Regenerative Medicine
Chapter-6 : Biomaterials
Biomedical Engineering for Global Health
Outlook for Orthopedics
© 2018 Global Market Insights, Inc. USA. All Rights Reserved Drug Integrated Polymer Fibers Market report for 2025 – Companies, applications,
MECHANICAL PROPERTIES OF BIOLOGICAL TISSUEAND TISSUE MECHANICS
Biomaterials Dr. Ahmed Moro.
Implant materials in orthopedic trauma David Eglin, Nicola Kildea
Biomaterials Dr. Ahmed Moro.
Presentation transcript:

How we make implants disappear after operations Andreas Karau June 21, 2016, Essen, Germany

June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Therapeutic needs: Product lifetime corresponds to required function Physiological properties Patient-specific solutions Avoiding further surgery Medical devices – increasing therapeutic needs of aging population We are working on new material systems that will meet these therapeutic requirements Page 2

Today: reparative medicine Treatment of symptoms Permanent medical devices Paradigm shift from reparative to regenerative medicine June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Vision: regenerative medicine Replace, produce, or regenerate cells, tissues, and organs Restore normal bodily functions Page 3

Regenerative medicine needs biodegradable materials, which take over the biological or mechanical function of the tissue for a time, and are finally replaced by human tissue We’re working to improve Mechanical properties Biocompatibility Customizability Step 1: Improved materials and solutions June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgeryPage 4

The bioimplant spectrum June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Biocompatible implants Biologized implants Biological implants Biocompatible/biodegradable materials Implants that release actives Surface functionalized implants In vivo cell coatingsBiohybrid systems Embedding engineered implants into tissues Tissue engineering Bioartifical organsCell therapy Engineered componentsCellular components Evonik today Page 5

Biodegradable medical polymers such as RESOMER ® / RESOMER ® Select are based on polylactic acid They degrade completely within the body into non-toxic components (CO 2, H 2 O) Mechanical properties are adjustable Degradation can be adjusted from weeks to several months Our starting point: biodegradable polymers June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery We are extending the range of applications in the direction of bioimplants Page 6

Osteoporosis alone results in roughly 8.9 million broken bones each year Commonly affects vertebrae or extremities Example: broken bones Need Problem June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Bone fixation usually accomplished with metal screws and plates These either have to remain in the body or be removed in a second operation Biodegradable materials are not yet strong enough or biocompatible enough for use in large, weight-bearing bones Healthy bonesOsteoporosis Page 7 Source: fotolia / peterjunaidy

Biodegradable materials with mechanical and biological properties more like those of bones: Strength similar to that of natural bones Support of bone formation Improved biocompatibility Goals Approach Combination of biodegradable polymers and inorganic fillers Ready-to-use granulate for producing screws, plates, etc. by a co-extrusion process Our approach to the problem of bone implants: biocomposites June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgeryPage 8

Applications for patient-specific implants June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Relatively large segments of bone sometimes need to be replaced, because of accident or disease Current options: Bone transplants or metal implants Frequently affects vertebrae, skull bones, or extremities Need Problem Future: use of 3D printing for producing patient-specific implants from biocompatible plastics The available materials are not suitable for clinical use Page 9 Source: fotolia / belekekin

Our approach: printable filaments and microparticles June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Materials used must meet regulatory requirements Materials must be processable using current 3D printing methods Goals Approach Production of suitable filaments and microparticles based on RESOMER ® or PEEK Page 10

Application: coronary heart disease June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Over two million stents are used throughout the world each year for the treatment of coronary heart disease—most of these are made of metal Need Problem Five percent of patients experience a thrombosis or restenosis within 5 years of receiving a metal stent Treating the patient again with another stent is not an option because the old metal stent is still in place Roughly 4 percent of biodegradable stents rupture when inserted Page 11

Evolution of stent technology June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery A coating based on RESOMER ® that releases an active agent aimed at reducing the risk of restenosis Stent made of RESOMER® that breaks down after 6 to 12 months Biodegradable stent Risk of complications: Available materials are very brittle and can lead to the development of thrombosis Risk of complications: Renewed vascular occlusion Metal stent that releases an active agent Normal metal stent Need: Materials for improved biodegradable stents Page 12

Approach Our approach: RESOMER ® with enhanced flow properties June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Improved material flow properties without sacrificing mechanical stability System solution using different biodegradable polymers and specific additives Goals PLLARESOMER ® ExtrusionReinforcement Enhance ductilityEnhance strength Ductility Strength Page 13

June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgery Production of patient-specific implants with biological tissues, made by culturing living cells on suitable polymer systems We are working on Polymer system biocompatibility Suitable 3D structures Suitable growth media Also in focus: biological implants Our goal: to become a leading solution provider for innovative medical device manufacturers Cells Polymer matrix Growth Media Page 14

Global polymer and applications expertise Darmstadt, Germany Manufacturing of RESOMER ® polymers Application lab Regulatory support team Birmingham, AL, USA Manufacturing of RESOMER ® Select polymers Regulatory support team Medical Devices Project House Shanghai, China Application lab Logistics center Regulatory support team Piscataway, NJ, USA Logistics center Medical Devices Project House Short-term strategic research unit Over 20 employees Close collaboration with polymer specialists from the business lines June 21, 2016 | R&D Press Briefing | How we make implants disappear after surgeryPage 15